CD4 and COVID-19: Consistent with this, significantly higher SARS-CoV-2-specific IFN-γ-producing CD4+ and CD8+ T cells were found in subjects with prior pulmonary disease, indicating that this condition may lead to a higher likelihood of future persistent cellular immune dysregulation after experiencing COVID-19 (24).